Dr. Duncan Moore serves as Partner at East West Capital Partners. He serves as Board Member at Cycle Pharma and Forward Pharma. Dr. Moore serves as Deputy Chairman at Braidlock. Dr. Moore serves as Senior Advisor at Hadean Ventures. Dr. Moore serves as Executive Chairman at Lamellar Biomedical. He is currently a partner at East West Capital. Prior to that he was a Managing Director at Morgan Stanley where he was global head of healthcare research. During this time he led the equity market positioning of a number of major healthcare companies including Wellcome, Sulzer Medica, Almirall, and Grupo Rovi. He trained as a biochemist at the University of Leeds and has a Ph.D. from the University of Cambridge. Whilst at Cambridge he co-founded a molecular diagnostics company with 2 colleagues. Following his move to the capital market in 1985, he was involved in setting up the bankInvest BioVenture funds and sat on the board of these funds until they were sold in 2009.